Partial federal government shutdown
HCA does not anticipate any immediate impacts to our services or disruption to provider payments at this time. We will continue to monitor the situation and share updates if anything changes.
HCA does not anticipate any immediate impacts to our services or disruption to provider payments at this time. We will continue to monitor the situation and share updates if anything changes.
The Health Care Authority (HCA) is partnering with the Department of Health (DOH) and AbbVie US LLC, a research-based global biopharmaceutical company, in an effort to eliminate hepatitis C (HCV) in Washington State by 2030.
Learn more about eliminating hepatitis C in Washington.
Mavyret allowed to be dispensed up to a 12-week supply
Effective for claims on or after March 1, 2024, Apple Health has increased the maximum allowable days’ supply for Mavyret (glecaprevir/pibrentasvir).
Pharmacies may dispense and submit claims for up to a 12-week (84 days) supply of Mavyret in a single fill. Mavyret is preferred and does not require prior authorization.
See HCA's hepatitis C treatment policy for more information or email Apple Health pharmacy.
HCA, DOH, and AbbVie are coordinating efforts to find individuals who are not yet treated; educate the health care workforce about screening and providing curative HCV treatment; and address barriers to care such as stigma, access to HCV providers, and the lack of urgency to treat among patients and providers.
In order to achieve HCV elimination in Washington State, DOH convened partners and stakeholders to develop the Hep C Free Washington plan. These include:
Action! This is a huge opportunity to rid our state of the most common blood borne disease in the United States – and now it is possible.
Effective immediately, we would like all providers licensed to treat HCV to screen and treat the target population. In order to support our provider community in this monumental effort, Apple Health (Medicaid) has made important policy changes:
The Health Care Authority (HCA) has built a hepatitis C (HCV) elimination dashboard for your use.
This interactive dashboard shows the total number of Washingtonians diagnosed and treated for hepatitis C since 2015. The map is broken into counties so you can see the impact in your community. You can filter by age, race/ethnicity, and gender. The graph shows the total patients diagnosed and total patients treated per year with denotations of HCA policy changes.
View the hepatitis C data dashboard.
HCA has launched a webinar series dedicated to highlighting efforts to eliminate HCV in Washington State.
| Date | Recording | Topics |
|---|---|---|
| January 15, 2025 |
A message from Governor Inslee on the fight against Hepatitis C |
|
| July 28, 2024 | World Hepatitis Day | |
|
November 6, 2020 |
HCA webinar series recording: Myth busting: treating hepatitis C in primary care |
Presenter: John Scott, MD, MSc
|
|
October 6, 2020 |
HCA webinar series recording: |
|
HCA and AbbVie are deploying an HCV Elimination awareness bus to areas of Washington State with high-risk HCV populations. This strategy is part of a national program to educate the population about the importance of screening and linkage to care. When a person visits the bus, they are able to get hep C antibody testing to determine if they may have the virus. View upcoming elimination awareness bus events.